HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 111 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $168,000 | -78.8% | 12,500 | -64.3% | 0.16% | -67.9% |
| Q2 2015 | $791,000 | +57.9% | 35,050 | 0.0% | 0.49% | +47.3% |
| Q1 2015 | $501,000 | +72.8% | 35,050 | +16.6% | 0.33% | +114.1% |
| Q4 2014 | $290,000 | -29.3% | 30,050 | -33.3% | 0.16% | -46.2% |
| Q3 2014 | $410,000 | -17.0% | 45,050 | -10.0% | 0.29% | -5.5% |
| Q2 2014 | $494,000 | -46.8% | 50,050 | -31.5% | 0.31% | -38.7% |
| Q1 2014 | $928,000 | -4.7% | 73,050 | +12.4% | 0.50% | +6.6% |
| Q4 2013 | $974,000 | +35.7% | 65,000 | 0.0% | 0.47% | +7.3% |
| Q3 2013 | $718,000 | +20.5% | 65,000 | -13.3% | 0.44% | +3.5% |
| Q2 2013 | $596,000 | – | 75,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $195,784,000 | 9.33% |
| BB BIOTECH AG | 5,846,564 | $57,764,000 | 2.74% |
| QVT Financial LP | 4,556,090 | $45,014,000 | 2.44% |
| Parametrica Management Ltd | 29,578 | $292,000 | 2.21% |
| SECTORAL ASSET MANAGEMENT INC | 4,389,682 | $43,370,000 | 1.84% |
| Belmont Global Advisors, Inc. | 257,000 | $2,539,000 | 1.83% |
| HARVEY CAPITAL MANAGEMENT INC | 394,550 | $3,898,000 | 1.40% |
| Lombard Odier Asset Management (USA) Corp | 1,350,000 | $13,338,000 | 0.70% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 6,199,685 | $61,253,000 | 0.63% |
| Callan Capital, LLC | 199,230 | $1,968,000 | 0.53% |